WCM
WST icon

Whitener Capital Management’s West Pharmaceutical WST Stock Holding History

Whitener Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed -$9K – 507
2018
Q4 		$9K Hold
100
– – 0.01% 328
2018
Q3 		$12K Buy
+100
New +$11.2K 0.01% 324
2018
Q2 		– Sell
-100
Closed -$8K – 414
2018
Q1 		$8K Hold
100
– – 0.01% 356
2017
Q4 		$9K Buy
+100
New +$9.8K 0.01% 334

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Whitener Capital Management's WST Position: Q1 2019 in Review

Whitener Capital Management sold out of West Pharmaceutical (WST) in Q1 2019, closing a stake of 100 shares — an estimated $9K sold.

Whitener Capital Management first reported a position in WST in Q4 2017 and held it in 4 quarters. The position peaked at $12K in Q3 2018. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

  • Whitener Capital Management reported no remaining West Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • Whitener Capital Management sold 100 West Pharmaceutical shares in Q1 2019, an estimated $9K.
  • Whitener Capital Management first reported a position in West Pharmaceutical in Q4 2017 and held it in 4 quarters.
  • Whitener Capital Management's West Pharmaceutical position peaked at $12K in Q3 2018.
  • 379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on Whitener Capital Management's 13F filing for Q1 2019, filed 2 May 2019.